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Summary
Leukocyte chemoattractants regulate many leukocyte
functions, including leukocyte chemotaxis, via the
Rho family of small GTPases that include RhoA, Cdc42,
and Rac [1–4]. Previous work has revealed mecha-
nisms by which chemoattractants regulate RhoA and
Cdc42 in mouse neutrophils [5–8], but the mecha-
nisms for regulation of Rac remain unclear even
though Rac is important for neutrophil functions
[9–13]. Here, we characterized P-Rex1, a G and
PIP3-regulated guanine nucleotide exchange factor
that was initially identified as a Rac activator in re-
sponse to chemoattractants [14], for its roles in the
regulation of Rac activity and neutrophil functions.
We generated a mouse line in which the P-Rex1 gene
is disrupted and found that P-Rex1 deficiency did not
significantly affect Rac1 activation but diminished
Rac2 activation in response to a chemoattractant
fMLP in mouse neutrophils. This preference for Rac2
may partially result from the apparent higher affinity
of P-Rex1 for Rac2 than for Rac1 because P-Rex1 was
more readily immunoprecipitated with Rac2S17N than
Rac1S17N. In addition, P-Rex1 deficiency significantly
attenuated fMLP-induced F actin formation and su-
peroxide production without affecting LPS- or PMA-
induced production. Furthermore, P-Rex1 deficiency
caused a chemotactic defect that is primarily attrib-
uted to a reduction in the migration rate rather than
directionality.
Results and Discussion
P-Rex1-Deficient Mice
To investigate the in vivo significance of P-Rex1 in its
regulation of Rac activity and neutrophil functions, we
generated a P-Rex1 mutant mouse line by using the
conventional gene-targeting approach. The part of the
P-Rex1 gene that contains exon 4 was replaced by a
neomycin-resistance gene-expression unit (see Figure
S1 in the Supplemental Data available with this article
online). Exon 4 encodes residues 135–169, which are
located in the center of the Dbl homology domain; thus,
its deletion should result in the loss of the GEF activity.
To validate this assumption, we expressed a P-Rex1
mutant form that lacks residues 135–169 and found that*Correspondence: zli@neuron.uchc.edu [Z.L.]; dwu@neuron.uchc.
edu [D.W.]the P-Rex1 mutant was indeed unable to stimulate
Rac1 activation in transfected 293 cells but that the
wild-type P-Rex1 could (data not shown). The targeted
P-Rex1 alleles in the mutant mice were confirmed by
both Southern blot (Figure S1) and PCR analyses (data
not shown). RT-PCR analysis of P-Rex1 mRNA from
neutrophils isolated from P-Rex1 mutant mice failed to
detect RNA containing P-Rex1 exon 4 (data not shown),
further confirming that the P-Rex1 gene has been suc-
cessfully mutated. P-Rex-1 mutant mice appeared to
develop normally and showed no apparent gross phe-
notypes under the specific pathogen-free housing con-
dition.
P-Rex1 Inactivation Failed to Affect
Chemoattractant-Induced Activation of Rac1
Previous in vitro results suggest that P-Rex1 may be an
important GEF for Rac activation in mouse neutrophils
[14]. Thus, we first examined if P-Rex1 inactivation af-
fected Rac1 activation by fMLP, a potent neutrophil
chemoattractant. To our surprise, mouse neutrophils
isolated from P-Rex1 mutant mice responded almost
as well as the wild-type neutrophils in Rac1 activation
(Figures 1A and 1B). The active Rac1 levels were deter-
mined by the PBD pull-down assay, performed as pre-
viously described [6, 15]. This result suggests that
P-Rex1 is not important for Rac1 activation in neutro-
phils.
P-Rex1 Deficiency Diminishes Rac2 Activation
Knowing that mouse neutrophils contain both Rac1 and
Rac2 at about the same levels, we examined the effect
of P-Rex1 deficiency on Rac2 activation by fMLP. Inter-
estingly, P-Rex1 deficiency almost completely abol-
ished fMLP-induced Rac2 activation (Figure 1C). This
result suggests that P-Rex1 may have a preference for
Rac2 over Rac1 and function as a predominant Rac2
GEF in mouse neutrophils. To understand the mecha-
nistic basis for this preference for Rac2 over Rac1, we
examined whether P-Rex1 has a higher affinity for Rac2
than Rac1. Previous studies have shown that GEFs
have high affinities for nucleotide-depleted GTPases
and that the S17N mutation in Rac molecules could
mimic the nucleotide-depleted state and thus allow
binding to Rac GEFs at high affinities [16, 17]. To com-
pare the affinities of P-Rex1 for Rac1S17N and Rac2S17N,
we expressed HA-Rac1S17N at three different levels
(Figure 1D, lanes 2–4), and HA-Rac2S17N was expressed
at a level in between the two lower levels of Rac1S17N
(Figure 1D; compare lane 5 with lanes 3 and 4). In addi-
tion, Myc-tagged P-Rex1 was coexpressed with the
Rac molecules. When the Rac molecules were immuno-
precipitated with an anti-HA antibody, we could only
detect P-Rex1 in cells expressing the highest level of
Rac1S17N, but not in those expressing the levels that
are similar to that of Rac2S17N (Figure 1D). These results
suggest that P-Rex1 may have a higher affinity for Rac2
than for Rac1.
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1875Figure 1. Rac Activation in P-Rex1 Mutant Neutrophils
(A and B) The levels of active Rac1 were determined in the Neutrophils via the GST-PBD pull-down assay. The neutrophils were stimulated
with 4 M (A) or varying doses (B) of fMLP. The bar charts show the results that were quantified and normalized against the levels of total
Rac1. There are no significant differences between wild-type and P-Rex-1 mutant neutrophils (p > 0.1).
(C) The levels of active and total Rac2 are shown. A significant reduction in fMLP-induced Rac2 activation was observed in P-Rex1-deficient
neutrophils (p < 0.05).
(D) HEK293 cells were cotransfected with Myc-tagged P-Rex1 and HA-tagged Rac1S17N or Rac2S17N as indicated in the figure. Immunoprecipi-
tation was carried out with an anti-Myc antibody, and the levels of Rac1 and Rac2 proteins in the immunocomplexes were determined by
Western analysis with the anti-HA antibody. P-Rex1 failed to pull down Rac1 when it was expressed at similar levels to Rac2.
Error bars are standard deviations.P-Rex1 Deficiency Results in a Partial Reduction
in Superoxide Production in Neutrophils
P-Rex1 was also previously shown to have a significant
role in the regulation of superoxide production [14].
Thus, we examined the effect of P-Rex1 deficiency on
chemoattractant-induced production of superoxides in
primary neutrophils. Bone marrow neutrophils isolated
from both wild-type and P-Rex1 null mice were stim-
ulated with fMLP, LPS, or PMA, and superoxide produc-
tion was measured by the isoluminol-based chemilumi-
nescence assay [18]. We found that P-Rex1 mutant
neutrophils produced significantly fewer superoxide
products than the wild-type neutrophils did (there was
more than a 60% reduction; Figure 2A). P-Rex1 defi-
ciency, on the other hand, did not appear to signifi-
cantly affect LPS or PMA-stimulated superoxide pro-
duction (Figures 2B and 2C). Because endotoxin LPS
and phorbal ester PMA stimulate superoxide produc-
tion via different mechanisms than those used by
chemoattractants, we conclude that P-Rex1 is primarily
involved in chemoattractant-induced superoxide pro-duction. These results are consistent with the previous
finding that P-Rex1 [14] and particularly Rac2, but not
Rac1 [10–12, 19], have a significant role in the regula-
tion of superoxide production in neutrophils.
P-Rex1 Mutant Neutrophils Are Defective
in Chemotaxis
As Rac2 deficiency has been shown to cause defects in
chemotaxis [9, 11, 12], we examined whether P-Rex1-
deficiency affects neutrophil chemotaxis. We initially
evaluated the role of P-Rex1 on chemotaxis by using
the modified Boyden chamber assay. We observed an
approximately 35% reduction in chemotactic indices
for P-Rex-1 mutant neutrophils compared to the wild-
type neutrophils (Figure 3A). The chemotaxis index is
the ratio of the number of migrated neutrophils in the
presence of chemoattractants to that in its absence. To
further characterize the effect of P-Rex1 deficiency on
neutrophil chemotaxis, we tracked individual cell mi-
gration by using a Dunn chemotaxis chamber and time-
lapse videomicroscopy. The Dunn chamber allows es-
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1876Figure 2. Effect of P-Rex1 Deficiency on Superoxide Production
(A–C) Superoxide anion levels were determined with an isoluminol
chemiluminescence assay. Mouse bone marrow neutrophils were
stimulated with 10 M of fMLP (A), 1 M of PMA (B), or 10 g/ml
of LPS (C). Kinetic plots of chemiluminescence intensity are shown.
AU stands for arbitrary unit.
Error bars are standard deviations.
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Ctablishment of a stable, shallow chemoattractant gradi-
ent and observation of cell migration in real time. We
found that P-Rex1 mutant neutrophils still could sense
and migrate along the chemoattractant gradient (Figure
3B; Movie S1 and Movie S2). Quantitative analysis of
the directionality (percentage of cells moving toward
the source of chemoattractant) revealed no differences
between P-Rex1 mutant and wild-type neutrophils (Fig-
ure 3C). However, when we examined the rate of cell
migration, we found that P-Rex1 mutant neutrophils mi-
grated significantly more slowly than the wild-type. This
is evidenced by a 33% reduction in the overall translo-
cation rate (Figure 3D), which is the translocation dis-
tance of each tracked cell in 10 min in the chemoattrac-
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cant gradient, and by the increases in the number of
ells migrating at slower rates (Figure 3E) than those of
he wild-type cells. Therefore, the chemotactic defects
bserved for the P-Rex-1 mutant neutrophils in the
oyden chamber assay may be due to the reduction in
he migration rate rather than to the loss of directional-
ty. This conclusion is further supported by the observa-
ion that P-Rex1 null neutrophils can polarize as well as
ild-type cells but move more slowly even under uni-
orm stimulation of a chemoattractant (Figure S2). Be-
ause casein-induced recruitment of neutrophils to the
eritonea showed a 25%–30% decrease in the number
f P-Rex1 mutant mice compared to the wild-type mice
Figure S3), it appears that P-Rex1 deficiency may also
ause a cell-migration defect in vivo.
Because F actin formation provides primary driving
orce for neutrophil locomotion, the defect in motility
ates of P-Rex1 null neutrophils suggests that there
hould be a defect in F actin formation. Thus, we exam-
ned fMLP-induced F actin formation and found that
-Rex1 defciency significantly attenuated the acute F
ctin formation at 15 s after ligand stimulation (Figures
F and 3G).
In this study, we made an unanticipated observation
hat P-Rex1 is not the major Rac1 GEF but is instead a
ignificant Rac2 GEF. This conclusion is further sup-
orted by the fact that the phenotypes observed with
he P-Rex1 mutant neutrophils resemble more what
as found with the Rac2 null neutrophils than with the
ac1 mutant neutrophils. Rac2 deficiency led to reduc-
ion in superoxide production, chemotaxis, and F actin
ormation [9–12], whereas Rac1 deficiency resulted in a
efect in directionality of cell migration [13]. Thus, Rac1
nd Rac2, which have been shown to regulate distinct
ellular effects [9–11], are also differentially regulated in
ouse neutrophils. Although the precise mechanism
or P-Rex1’s preference for Rac2 over Rac1 is not known,
his preference may be at least in part explained by
he apparent higher affinity of P-Rex1 for the Rac2S17N
utant. This higher Rac2 affinity observed in a precipi-
ation assay may require modifications on P-Rex1 or
ac (less likely) or the presence of scaffold proteins
ecause no significant preference of purified recombi-
ant P-Rex-1 for purified recombinant Rac2 over Rac1
as observed (H. Welch, personal communication). The
ifferent regulation of downstream targets by the two
ac isoforms appears to lie in the difference in their
-terminal amino acid sequences [20]. It is not known
f these sequences are also responsible for the differ-
nce in regulation by P-Rex1. It is also not known why
he two Rac isoforms are regulated via different mecha-
isms given that they are both activated by chem-
attractants. The difference in their regulation of down-
tream effectors may provide a rationale because cells
ay need to regulate different cell processes with vary-
ng dynamics and magnitudes.
Knowing that P-Rex1 deficiency fails to affect Rac1
ctivation in mouse neutrophils and that P-Rex2, the
lose homolog of P-Rex1, is not expressed in myeloid
ells [21], there have to be other mechanisms for Rac
ctivation by chemoattractants. Although PIP3 may
ave a role in modulating Rac activation, PI3Kγ defi-
iency, which abrogates chemoattractant-induced pro-
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1877Figure 3. Effects of P-Rex1 Deficiency on Neutrophil Chemotaxis and F Actin Formation
(A) Chemotaxis of bone marrow neutrophils was analyzed via the modified Boyden chamber assay. The number of cells that migrated to the
bottom side of the filter was counted. The chemotaxis indices are shown in the table.
(B–E) Neutrophil chemotaxis was analyzed in a Dunn chamber with time-lapse videomicroscopy. A shallow gradient of fMLP was established
in the Dunn chamber. Cell migration was tracked at 5 s intervals. The migratory tracks of some representative cells are shown in (B). The
percentages of cells that migrated toward to the source of chemoattractant are shown in (C). Translocation rates that were calculated based
on the total cell migration distance over 10 min are shown in (D). Percentages of cells that migrated at different rates are charted in (E). The
results for Panels (C–E) are from five independent experiments. A total of 140 mutants and 136 wild-type cells were analyzed.
(F and G) F actin levels were determined with flow-cytometric analysis of neutrophils labeled with FITC-conjugated phalloidin. Mean fluores-
cence intensities are shown in (F), and relative changes are shown in (G).
Error bars are standard deviations.duction of PIP3 in mouse neutrophils [22–24], had little
effect on Rac1 activation [22]. One possibility is a
mechanism that involves the members of the Dock
family. Although the Dock proteins do not contain theDbl homology domains that are typical of many guanine
nucleotide exchange factors for the Rho family of small
GTPases, they have been shown to regulate the mem-
bers of this small GTPase family [25, 26]. Notably, Dock2
Current Biology
1878deficiency was shown to abrogate Rac1 activation in
mouse T cells [27]. However, Dock2 deficiency had no
effects on Rac activation in neutrophils. It is possible
that another member of this family may function as a
primary Rac1 activator in mouse neutrophils.
Experimental Procedures
Cell Culture, Transfection, and Construction
of Expression Plasmids
Human embryonic kidney A293T cells were maintained as pre-
viously described [6]. For transfection, cells were seeded at 2 × 105
cells/well in six-well plates and transfected with 1 g DNA/well via
Lipofectamine Plus (Invitrogen, CA), as suggested by the manufac-
turer. Cell extracts were collected 24 hr after transfection. The wild-
type and mutant forms of human P-Rex1, Rac1, and Rac2 were
generated by PCR with the high-fidelity thermostable DNA poly-
merase Pfu (Stratagene, CA). The expression of these molecules
was driven by a CMV promoter. All constructs were verified by
DNA sequencing.
Immunoprecipitation and PBD Pull-Down Assay
Cells were lysed in the lysis buffer (5 mM HEPES [pH 7.4], 150 mM
NaCl, 15 mM NaF, 2 mM EDTA, 1 mM EGTA, 10% glycerol, 1%
Triton X-100, 20 mM β-glycerophosphate, 1 mM orthovanadate, 1
mM sodium pyrophosphate, 10 g/ml aprotinin, and 10 g/ml leu-
peptin). The cell lysates were subject to high-speed centrifugation.
The supernatants were then incubated with an antibody and 20 l
of protein A/G-Sepharose beads (Santa Cruz Biotech, CA) for 2 hr
at 4°C. The immunocomplexes were pelleted and washed three
times with cold lysis buffer in the absence of protease and phos-
phatase inhibitors. The proteins were released from beads by being
boiled in SDS sample buffer. The samples were analyzed by West-
ern blotting. The results were visualized with a Raytest imaging
system with a cooled CCD camera. The PBD pull-down assay was
carried out as described previously [6].
Neutrophil Preparation and Stimulation
Murine bone marrow neutrophils were prepared by centrifugation
through Percoll gradients. Purified neutrophils were suspended in
Hanks’ buffer (0.14 M NaCl, 5.4 mM KCl, 1 mM Tris, 1.1 mM CaCl2,
0.4 mM MgSO4, and 1 mM HEPES [pH 7.2]) containing 5 mg/ml
BSA. For the modified Boyden chamber assay, 1,000,000 cells were
loaded to the top chamber. Two hours later, the number of cells
that had migrated to the bottom side of the membrane that sepa-
rates the chambers were stained and counted. For the Dunn che-
motaxis chamber assay, isolated neutrophils were allowed to ad-
here to glass coverslips for 5 min at 37°C. The coverslips were then
rinsed and placed on the Dunn chamber for chemotaxis assays.
Cell migration was recorded with time-lapse videomicroscopy. The
microscope was equipped with differential interference contrast
optics and a 20× objective. Images were captured at 5 s intervals
with a PXL-EEV37 CCD camera (Photometrics, Waterloo, Ontario,
Canada) and Metamorph imaging software (West Chester, PA).
Time-lapse video images were used for tracing cell-migration track
and calculating the final position of a cell relative to its starting
position and migration rates. Time-lapse videomicroscopy data
were also analyzed with the Metamorph software to determine mi-
gration parameters as described previously [28].
Superoxide Assay
Murine neutrophil superoxide production was measured by isolum-
inol chemiluminescence assay [18, 28]. Isolated bone marrow neu-
trophils were suspended in Hank’s buffer (Gibco) at 10 × 106/ml on
ice. Fifty microliters of cells were mixed with 40 l HRP (100U/ml)
and 80 l isoluminol (125 M) in a well of a 96-well plate. FMLP (10
M), PMA (1 M), or LPS (10 g/ml) was used for stimulation, and
chemiluminescence was detected by a luminometer. The assay
was run in triplicate, and neutrophils from three P-Rex1 mutant
mice and wild-type littermates were assayed in parallel.
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solated bone marrow neutrophils were stimulated by fMLP and
ixed by paraformedehye (4%) for 20 min at room temperature, and
ells were centrifuged and washed with phosphate-buffered saline
PBS) twice, resuspended with PBS containing Alexa488-labeled
halloidin (0.4U) and 20 mg/l lysolecithin (L-4129 sigma), and incu-
ated for 30 min at room temperature. Samples were then analyzed
y FASC [6].
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